INSPIREMD 1/18 DL-0001 (F:II2) — Market Cap & Net Worth
Market Cap & Net Worth: INSPIREMD 1/18 DL-0001 (II2)
INSPIREMD 1/18 DL-0001 (F:II2) has a market capitalization of $43.59 Million (€37.29 Million) as of May 5, 2026. Listed on the F stock exchange, this Germany-based company holds position #22374 globally and #1971 in its home market, demonstrating a -16.19% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying INSPIREMD 1/18 DL-0001's stock price €0.88 by its total outstanding shares 42370995 (42.37 Million).
INSPIREMD 1/18 DL-0001 Market Cap History: 2016 to 2026
INSPIREMD 1/18 DL-0001's market capitalization history from 2016 to 2026. Data shows change from $2.80 Trillion to $43.59 Million (-71.32% CAGR).
INSPIREMD 1/18 DL-0001 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how INSPIREMD 1/18 DL-0001's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of II2 by Market Capitalization
Companies near INSPIREMD 1/18 DL-0001 in the global market cap rankings as of May 5, 2026.
Key companies related to INSPIREMD 1/18 DL-0001 by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #145 globally with a market cap of $152.22 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #211 globally with a market cap of $111.32 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #229 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (XETRA:2M6): Ranked #236 globally with a market cap of $101.71 Billion USD ( €87.00 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #145 | Abbott Laboratories | NYSE:ABT | $152.22 Billion | $87.54 |
| #211 | Stryker Corporation | NYSE:SYK | $111.32 Billion | $290.88 |
| #229 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #236 | Medtronic PLC | XETRA:2M6 | $101.71 Billion | €67.76 |
INSPIREMD 1/18 DL-0001 Historical Marketcap From 2016 to 2026
Between 2016 and today, INSPIREMD 1/18 DL-0001's market cap moved from $2.80 Trillion to $ 43.59 Million, with a yearly change of -71.32%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €43.59 Million | -42.11% |
| 2025 | €75.29 Million | -40.62% |
| 2024 | €126.81 Million | +7.56% |
| 2023 | €117.90 Million | +187.68% |
| 2022 | €40.98 Million | -66.91% |
| 2021 | €123.84 Million | -39.74% |
| 2020 | €205.53 Million | -65.64% |
| 2019 | €598.14 Million | -86.00% |
| 2018 | €4.27 Billion | -96.96% |
| 2017 | €140.44 Billion | -94.98% |
| 2016 | €2.80 Trillion | -- |
End of Day Market Cap According to Different Sources
On May 5th, 2026 the market cap of INSPIREMD 1/18 DL-0001 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $43.59 Million USD |
| MoneyControl | $43.59 Million USD |
| MarketWatch | $43.59 Million USD |
| marketcap.company | $43.59 Million USD |
| Reuters | $43.59 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About INSPIREMD 1/18 DL-0001
InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery and other vascular diseases in Europe, Latin America, the Middle East, and the Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding car… Read more